Biologic functions and signaling of the interleukin-4 receptor complexes

Immunobiology

Volumn 201, Issue 3-4, 2000, Pages 285-307

  Gessner, André ^a   Röllinghoff, Martin ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL KINASE; STAT5 PROTEIN; STAT6 PROTEIN;

ALLOTYPE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; CELL PROLIFERATION; CHEMICAL STRUCTURE; GENE ACTIVATION; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION;

EID: 19244381836     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(00)80084-4     Document Type: Article

References (143)

1. CHOI, P., and H. REISER. 1998. IL-4: role in disease and regulation of production [editorial]. Clin Exp Immunol 113: 317.
2. PAUL, W. E. 1991. Interleukin-4: a prototypic immunoregulatory lymphokine. Blood 77: 1859.
3. BOGDAN, C., and C. NATHAN. 1993. Modulation of macrophage function by transforming growth factor beta, interleukin-4, and interleukin-10. Ann N Y Acad Sci 685: 713.
4. SADICK, M. D., F. P. HEINZEL, B. J. HOLADAY, R. T. PU, R. S. DAWKINS, and R. M. LOCKSLEY. 1990. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism. J Exp Med 171: 115.
5. ROMANI, L., A. MENCACCI, U. GROHMANN, S. MOCCI, P. MOSCI, P. PUCCETTI, and F. BISTONI. 1992. Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis. J Exp Med 176: 19.
6. GESSNER, A., K. SCHROPPEL, A. WILL, K. H. ENSSLE, L. LAUFFER, and M. ROLLINGHOFF. 1994. Recombinant soluble interleukin-4 (IL-4) receptor acts as an antagonist of IL-4 in murine cutaneous Leishmaniasis. Infect Immun 62: 4112.
7. PUCCETTI, P., A. MENCACCI, E. CENCI, R. SPACCAPELO, P. MOSCI, K. H. ENSSLE, L. ROMANI, and F. BISTONI. 1994. Cure of murine candidiasis by recombinant soluble interleukin-4 receptor. J Infect Dis 169: 1325.
8. KOPF, M., G. LE GROS, M. BACHMANN, M. C. LAMERS, H. BLUETHMANN, and G. KOHLER. 1993. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362: 245.
9. LOHOFF, M., A. GESSNER, C. BOGDAN, and M. RÖLLINGHOFF. 1998. The Th1/Th2 paradigm and experimental murine leishmaniasis. Int Arch Allergy Immunol 115: 191.
10. ERB, K. J., B. RUGER, M. VON BREVERN, B. RYFFEL, A. SCHIMPL, and K. RIVETT. 1997. Constitutive expression of interleukin (IL)-4 in vivo causes autoimmune-type disorders in mice. J Exp Med 185: 329.
11. ABBAS, A. K., K. M. MURPHY, and A. SHER. 1996. Functional diversity of helper T lymphocytes. Nature 383: 787.
12. CHEN, Y., V. K. KUCHROO, J. INOBE, D. A. HAFLER, and H. L. WEINER. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265: 1237.
13. SANTIAGO, M. L., L. FOSSATI, C. JACQUET, W. MULLER, S. IZUI, and L. REININGER. 1997. Interleukin-4 protects against a genetically linked lupus-like autoimmune syndrome. J Exp Med 185: 65.
14. BROWN, K. D., S. M. ZURAWSKI, T. R. MOSMANN, and G. ZURAWSKI. 1989. A family of small inducible proteins secreted by leukocytes are members of a new superfamily that includes leukocyte and fibroblast-derived inflammatory agents, growth factors, and indicators of various activation processes. J Immunol 142: 679.
15. HOSHINO, T., R. T. WINKLER-PICKETT, A. T. MASON, J. R. ORTALDO, and H. A. YOUNG. 1999. IL-13 production by NK cells: IL-13-producing NK and T cells are present in vivo in the absence of IFN-gamma. J Immunol 162: 51.
16. PUNNONEN, J., G. AVERSA, B. G. COCKS, A. N. MCKENZIE, S. MENON, G. ZURAWSKI, R. DE WAAL MALEFYT, and J. E. DE VRIES. 1993. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci U S A 90: 3730.
17. WILLS-KARP, M., J. LUYIMBAZI, X. XU, B SCHOFIELD., T. Y. NEBEN, C. L. KARP, and D. D. DONALDSON. 1998. Interleukin-13: central mediator of allergic asthma [see comments]. Science 282: 2258.
18. GRUNIG, G., M. WARNOCK, A. E. WAKIL, R. VENKAYYA, F. BROMBACHER, D. M. RENNICK, D. SHEPPARD, M. MOHRS, D. D. DONALDSON, R. M. LOCKSLEY, and D. B. CORRY. 1998. Requirement for IL-13 independently of IL-4 in experimental asthma [see comments]. Science 282: 2261.
19. LOWENTHAL, J. W., B. E. CASTLE, J. CHRISTIANSEN, J. SCHREURS, D. RENNICK, N. ARAI, P. HOY, Y. TAKEBE, and M. HOWARD. 1988. Expression of high affinity receptors for murine interleukin 4 (BSF-1) on hemopoietic and nonhemopoietic cells. J Immunol 140: 456.
20. MOSLEY, B., M. P. BECKMANN, C. J. MARCH, R. L. IDZERDA, S. D. GIMPEL, T. VANDENBOS, D. FRIEND, A. ALPERT, D. ANDERSON, J., JACKSON and et al. 1989. The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms. Cell 59: 335.
21. HARADA, N., B. E. CASTLE, D. M. GORMAN, N. ITOH, J. SCHREURS, R. L. BARRETT, M. HOWARD, and A. MIYAJIMA. 1990. Expression cloning of a cDNA encoding the murine interleukin 4 receptor based on ligand binding. Proc Natl Acad Sci U S A 87: 857.
22. IDZERDA, R. L., C. J. MARCH, B. MOSLEY, S. D. LYMAN, T. VANDEN BOS, S. D. GIMPEL, W. S. DIN, K. H. GRABSTEIN, M. B. WIDMER, L. S. PARK, and et al. 1990. Human interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily. J Exp Med 171: 861.
23. GALIZZI, J. P., C. E. ZUBER, N. HARADA, D. M. GORMAN, O. DJOSSOU, R. KASTELEIN, J. BANCHEREAU, M. HOWARD, and A. MIYAJIMA. 1990. Molecular cloning of a cDNA encoding the human interleukin 4 receptor. Int Immunol 2: 669.
24. HAGE, T., W. SEBALD, and P. REINEMER. 1999. Crystal structure of the interleukin-4/receptor alpha chain complex reveals a mosaic binding interface. Cell 97: 271.
25. KONDO, M., T TAKESHITA., N. ISHII, M. NAKAMURA, S. WATANABE, K. ARAI, and K. SUG-AMURA. 1993. Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4 [see comments]. Science 262: 1874.
26. WATANABE, S., M. KONDO, K. TAKATSU, K. SUGAMURA, and K. ARAI. 1995. Involvement of the interleukin-2 receptor gamma subunit in interleukin-4-dependent activation of mouse hematopoietic cells and splenic B cells. Eur J Immunol 25: 126.
27. SUGAMURA, K., H. ASAO, M. KONDO, N. TANAKA, N. ISHII, M. NAKAMURA, and T. TAKESHITA. 1995. The common gamma-chain for multiple cytokine receptors. Adv Immunol 59: 225.
28. NOGUCHI, M., H. YI, H. M. ROSENBLATT, A. H. FILIPOVICH, S. ADELSTEIN, W. S. MODI, O. W. MCBRIDE, and W. J. LEONARD. 1993. Interleukin-2 receptor gamma chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73: 147.
29. DISANTO, J. P., W. MULLER, D. GUY-GRAND, A. FISCHER, and K. RAJEWSKY. 1995. Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. Proc Natl Acad Sci U S A 92: 377.
30. CAO, X., E. W. SHORES, J. HU-LI, M. R. ANVER, B. L. KELSALL, S. M. RUSSELL, J. DRAGO, M. NOGUCHI, A GRINBERG., E. T. BLOOM, and et al. 1995. Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity 2: 223.
31. LEONARD, W. J. 1996. The molecular basis of X-linked severe combined immunodeficiency: defective cytokine receptor signaling. Annu Rev Med 47: 229.
32. MATTHEWS, D. J., P. A. CLARK, J. HERBERT, G. MORGAN, R. J. ARMITAGE, C. KINNON, A. MINTY, K. H. GRABSTEIN, D CAPUT., P. FERRARA, and et al. 1995. Function of the interleukin-2 (IL-2) receptor gamma-chain in biologic responses of X-linked severe combined immunodeficient B cells to IL-2, IL-4, IL-13, and IL-15. Blood 85: 38.
33. MATTHEWS, D. J., L. HIBBERT, K. FRIEDRICH, A. MINTY, and R. E. CALLARD. 1997. X-SCID B cell responses to interleukin-4 and interleukin-13 are mediated by a receptor complex that includes the interleukin-4 receptor alpha chain (p140) but not the gamma c chain. Eur J Immunol 27: 116.
34. CAPUT, D., P. LAURENT, M. KAGHAD, J. M. LELIAS, S. LEFORT, N. VITA, and P. FERRARA. 1996. Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain. J Biol Chem 271: 16921.
35. HILTON, D. J., J. G. ZHANG, D. METCALF, W. S. ALEXANDER, N. A. NICOLA, and T. A. WILLSON. 1996. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc Natl Acad Sci U S A 93: 497.
36. MILOUX, B., P LAURENT., O. BONNIN, J. LUPKER, D. CAPUT, N. VITA, and P. FERRARA. 1997. Cloning of the human IL-13R alpha1 chain and reconstitution with the IL4R alpha of a functional IL-4/IL-13 receptor complex. FEBS Lett 401: 163.
37. LIN, J. X., T. S. MIGONE, M. TSANG, M. FRIEDMANN, J. A. WEATHERBEE, L. ZHOU, A. YAMAUCHI, E. T. BLOOM, J. MIETZ, S. JOHN, and et al. 1995. The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 2: 331.
38. TONY, H. P., B. J. SHEN, P. REUSCH, and W. SEBALD. 1994. Design of human interleukin-4 antagonists inhibiting interleukin-4-dependent and interleukin-13-dependent responses in T-cells and B-cells with high efficiency. Eur J Biochem 225: 659.
39. AVERSA, G., J. PUNNONEN, B. G. COCKS, R. DE WAAL MALEFYT, F., JR. VEGA, S. M. ZURAWSKI, G. ZURAWSKI, and J. E. DE VRIES. 1993. An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors. J Exp Med 178: 2213.
40. GRUNEWALD, S. M., S. KUNZMANN, B. SCHNARR, J. EZERNIEKS, W. SEBALD, and A. DUSCHL. 1997. A murine interleukin-4 antagonistic mutant protein completely inhibits interleukin-4-induced cell proliferation, differentiation, and signal transduction. J Biol Chem 272: 1480.
41. SHANAFELT, A. B., C. P. FORTE, J. J. KASPER, L. SANCHEZ-PESCADOR, M. WETZEL, R. GUNDEL, and J. M. GREVE. 1998. An immune cell-selective interleukin 4 agonist. Proc Natl Acad Sci U S A 95: 9454.
42. SCHNARE, M., H. BLUM, S. JUTTNER, M. ROLLINGHOFF, and A. GESSNER. 1998. Specific antagonism of type I IL-4 receptor with a mutated form of murine IL-4. J Immunol 161: 3484.
43. NKELMS, K., H. HUANG, J. RYAN, A. KEEGAN, and W. E. PAUL. 1998. Interleukin-4 receptor signalling mechanisms and their biological significance. Adv Exp Med Biol 452: 37.
44. MURATA, T., N. I. OBIRI, and R. K. PURI. 1998. Structure of and signal transduction through interleukin-4 and interleukin-13 receptors (review). Int J Mol Med 1: 551.
45. IZUHARA, K., and T. SHIRAKAWA. 1999. Signal transduction via the interleukin-4 receptor and its correlation with atopy. Int J Mol Med 3: 3.
46. NELMS, K., A. D. KEEGAN, J. ZAMORANO, J. J. RYAN, and W. E. PAUL. 1999. The IL-4 receptor: signaling mechanisms and biologic functions [In Process Citation]. Annu Rev Immunol 17: 701.
47. MURATA, T., P. D. NOGUCHI, and R. K. PURI. 1996. IL-13 induces phosphorylation and activation of JAK2 Janus kinase in human colon carcinoma cell lines: similarities between IL-4 and IL-13 signaling. J Immunol 156: 2972.
48. DEUTSCH, H. H., K. KOETTNITZ, J. CHUNG, and F. S. KALTHOFF. 1995. Distinct sequence motifs within the cytoplasmic domain of the human IL-4 receptor differentially regulate apoptosis inhibition and cell growth. J Immunol 154: 3696.
49. CHEN, X. H., B. K. PATEL, L. M. WANG, M. FRANKEL, N. ELLMORE, R. A. FLAVELL, W. J. LAROCHELLE, and J. H. PIERCE. 1997. Jak1 expression is required for mediating interleukin-4-induced tyrosine phosphorylation of insulin receptor substrate and Stat6 signaling molecules. J Biol Chem 272: 6556.
50. WANG, H. Y., J. ZAMORANO, J. L. YOERKIE, W. E. PAUL, and A. D. KEEGAN. 1997. The IL-4-induced tyrosine phosphorylation of the insulin receptor substrate is dependent on JAK1 expression in human fibrosarcoma cells. J Immunol 158: 1037.
51. YIN, T., M. L. TSANG, and Y. C. YANG. 1994. JAK1 kinase forms complexes with interleukin-4 receptor and 4PS/insulin receptor substrate-1-like protein and is activated by interleukin-4 and interleukin-9 in T lymphocytes. J Biol Chem 269: 26614.
52. Miyazaki, T., Takaoka, A., Nogueira, L., Dikic, I., Fujii, H., Tsujino, S., Mitani, Y., Maeda, M., Schlessinger, J., and Taniguchi, T. 1998. Pyk2 is a downstream mediator of the IL-2 receptor-coupled Jak signaling pathway. Genes Dev 12: 770.
53. YIN, T., S. R. KELLER, F. W. QUELLE, B. A. WITTHUHN, M. L. TSANG, G. E. LIENHARD, J. N. IHLE, and Y. C. YANG. 1995. Interleukin-9 induces tyrosine phosphorylation of insulin receptor substrate-1 via JAK tyrosine kinases. J Biol Chem 270: 20497.
54. OAKES, S. A., F. CANDOTTI, J. A. JOHNSTON, Y. Q. CHEN, J. J. RYAN, N. TAYLOR, X. LIU, L. HENNIGHAUSEN, L. D. NOTARANGELO, W. E. PAUL, R. M. BLAESE, and J. J. O'SHEA. 1996. Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and independent pathways. Immunity 5: 605.
55. FUJIWARA, H., S. H. HANISSIAN, A. TSYTSYKOVA, and R. S. GEHA. 1997. Homodimerization of the human interleukin 4 receptor alpha chain induces Cepsilon germline transcripts in B cells in the absence of the interleukin 2 receptor gamma chain. Proc Natl Acad Sci U S A 94: 5866.
56. ANDERSSON, A., S. M. GRUNEWALD, A. DUSCHL, A. FISCHER, and J. P. DISANTO. 1997. Mouse macrophage development in the absence of the common gamma chain: defining receptor complexes responsible for IL-4 and IL-13 signaling. Eur J Immunol 27: 1762.
57. MURATA, T., J. TAGUCHI, and R. K. PURI. 1998. Interleukin-13 receptor alpha' but not alpha chain: a functional component of interleukin-4 receptors. Blood 91: 3884.
58. RYAN, J. J., L. J. MCREYNOLDS, H. HUANG, K. NELMS, and W. E. PAUL. 1998. Characterization of a mobile Stat6 activation motif in the human IL-4 receptor. J Immunol 161: 1811.
59. RICHTER, G., G. HEIN, T. BLANKENSTEIN, and T. DIAMANTSTEIN. 1995. The rat interleukin 4 receptor: coevolution of ligand and receptor. Cytokine 7: 237.
60. HOU, J., U. SCHINDLER, W. J. HENZEL, T. C. HO, M. BRASSEUR, and S. L. MCKNIGHT. 1994. An interleukin-4-induced transcription factor: IL-4 Stat. Science 265: 1701.
61. TAKEDA, K., T TANAKA., W SHI., M. MATSUMOTO, M. MINAMI, S. KASHIWAMURA, K. NAKANISHI, N. YOSHIDA, T. KISHIMOTO, and S. AKIRA. 1996. Essential role of Stat6 in IL-4 signalling. Nature 380: 627.
62. URBAN, J. F., JR., N. NOBEN-TRAUTH, D. D. DONALDSON, K. B. MADDEN, S. C MORRIS., M. COLLINS, and F. D. FINKELMAN. 1998. IL-13, IL-4Ralpha, and Stat6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. Immunity 8: 255.
63. KAPLAN, M. H., J. R. WHITFIELD, D. L. BOROS, and M. J. GRUSBY. 1998. Th2 cells are required for the Schistosoma mansoni egg-induced granulomatous response. J Immunol 160: 1850.
64. DENT, A. L., T. M. DOHERTY, W. E. PAUL, A. SHER, and L. M. STAUDT. 1999. BCL-6-Deficient mice reveal an IL-4-independent, STAT6-dependent pathway that controls susceptibility to infection by leishmania major [In Process Citation]. J Immunol 163: 2098.
65. STAMM, L. M., A. RAISANEN-SOKOLOWSKI, M. OKANO, M. E. RUSSELL, J. R. DAVID, and A. R. SATOSKAR. 1998. Mice with STAT6-targeted gene disruption develop a Th1 response and control cutaneous leishmaniasis. J Immunol 161: 6180.
66. KUPERMAN, D., B. SCHOFIELD, M. WILLS-KARP, and M. J. GRUSBY. 1998. Signal transducer and activator of transcription factor 6 (Stat6)-deficient mice are protected from antigen-induced airway hyperresponsiveness and mucus production. J Exp Med 187: 939.
67. SHIMODA, K., J. VAN DEURSEN, M. Y. SANGSTER, S. R. SARAWAR, R. T. CARSON, R. A. TRIPP, C. CHU, F. W. QUELLE, T. NOSAKA, D. A. VIGNALI, P. C DOHERTY., G. GROSVELD, W. E. PAUL, and J. N. IHLE. 1996. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 380: 630.
68. KAPLAN, M. H., U. SCHINDLER, S. T. SMILEY, and M. J. GRUSBY. 1996. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4: 313.
69. LINEHAN, L. A., W. D. WARREN, P. A. THOMPSON, M. J. GRUSBY, and M. T. BERTON. 1998. STAT6 is required for IL-4-induced germline Ig gene transcription and switch recombination. J. Immunol. 161: 302.
70. KOTANIDES, H., and N. C. REICH. 1996. Interleukin-4-induced STAT6 recognizes and activates a target site in the promoter of the interleukin-4 receptor gene. J Biol Chem 271: 25555.
71. PATEL, B. K. R., J. H. PIERCE, and W. J. LAROCHELLE. 1998. Regulation of interleukin 4-mediated signaling by naturally occurring dominant negative and attenuated forms of human Stat6. Proc. Natl. Acad. Sci. U S A 95: 172.
72. ROLLING, C., D. TRETON, S. PELLEGRINI, P. GALANAUD, and Y. RICHARD. 1996. IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells. FEBS Lett 393: 53.
73. FRIEDRICH, K., W. KAMMER, I. ERHARDT, S. BR#NDLEIN, W. SEBALD, and R. MORIGGL. 1999. Activation of STATS by IL-4 relies on Janus kinase function but not on receptor tyrosinc phosphorylation, and can contribute to both cell proliferation and gene regulation. Int Immunol 11: 1283.
74. CASTRO, A., T. K. SENGUPTA, D. C. RUIZ, E. YANG, and L. B. IVASHKIV. 1999. IL-4 selectively inhibits IL-2-triggered StatS activation, but not proliferation, in human T cells. J Immunol 162: 1261.
75. KEEGAN, A. D., K. NELMS, M. WHITE, L. M. WANG, J. H. PIERCE, and W. E. PAUL. 1994. An IL-4 receptor region containing an insulin receptor motif is important for IL-4-mediated IRS-I phosphorylation and cell growth. Cell 76: 811.
76. SUN, X. J., L. M. WANG, Y. ZHANG, L. YENUSH, M. G. MYERS, JR., E. GLASHEEN, W. S. LANE, J. H. PIERCE, and M. F. WHITE. 1995. Role of IRS-2 in insulin and cytokine signalling. Nature 377: 173.
77. JOHNSTON, J. A., L. M. WANG, E. P. HANSON, X. J. SUN, M. F WHITE., S. A. OAKES, J. H. PIERCE, and J. J. O'SHEA. 1995. Interleukins 2, 4, 7, and 15 stimulate tyrosine phosphorylation of insulin receptor substrates 1 and 2 in T cells. Potential role of JAK kinases. J Biol Chem 270: 28527.
78. WELHAM, M. J., H. BONE, M. LEVINGS, L. LEARMONTH, L. M. WANG, K. B. LESLIE, J. H. PIERCE, and J. W. SCHRADER. 1997. Insulin receptor substrate-2 is the major 170-kDa protein phosphorylated on tyrosine in response to cytokines in murine lymphohemopoietic cells. J Biol Chem 272: 1377.
79. LAVAN, B. E., V. R. FANTIN, E. T. CHANG, W. S. LANE, S. R. KELLER, and G. E. LIENHARD. 1997. A novel 160-kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family. J Biol Chem 272: 21403.
80. LAVAN, B. E., W. S. LANE, and G. E. LIENHARD. 1997. The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family. J Biol Chem 272: 11439.
81. WOLF, G., T. TRUB, E. OTTINGER, L. GRONINGA, A. LYNCH, M. F. WHITE, M. MIYAZAKI, J. LEE, and S. E. SHOELSON. 1995. PTB domains of IRS-1 and Shc have distinct but overlapping binding specificities. J Biol Chem 270: 27407.
82. ZHOU, M. M., B. HUANG, E. T. OLEJNICZAK, R. P. MEADOWS, S. B. SHUKER, M. MIYAZAKI, T. TRUB, S. E. SHOELSON, and S. W. FESIK. 1996. Structural basis for IL-4 receptor phosphopeptide recognition by the IRS-1 PTB domain. Nat Struct Biol 3: 388.
83. GOLD, M. R., V. DURONIO, S. P. SAXENA, J. W. SCHRADER, and R. AEBERSOLD. 1994. Multiple cytokines activate phosphatidylinositol 3-kinase in hemopoietic cells. Association of the enzyme with various tyrosine-phosphorylated proteins. J Biol Chem 269: 5403.
84. IKIZAWA, K., K. KAJIWARA, Y BASAKI., T. KOSHIO, and Y. YANAGIHARA. 1996. Evidence for a role of phosphatidylinositol 3-kinase in IL-4-induced germline C epsilon transcription. Cell Immunol 170: 134.
85. IZUHARA, K., and N. HARADA. 1996. Interleukin-4 activates two distinct pathways of phosphatidylinositol-3 kinase in the same cells. Biochem Biophys Res Commun 229: 624.
86. IZUHARA, K., R. A. FELDMAN, P. GREER, and N. HARADA. 1996. Interleukin-4 induces association of the c-fes proto-oncogene product with phosphatidylinositol-3 kinase. Blood 88: 3910.
87. IZUHARA, K., R. A. FELDMAN, P. GREER, P., and N. HARADA. 1994. Interaction of the c-fes proto-oncogene product with the interleukin-4 receptor. J Biol Chem 269: 18623.
88. MINSHALL, C., S. ARKINS, R. DANTZER, G. G. FREUND, and K. W. KELLEY. 1999. Phosphatidylinositol 3′-kinase, but not S6-kinase, is required for insulin-like growth factor-I and IL-4 to maintain expression of Bcl-2 and promote survival of myeloid progenitors. J Immunol 162: 4542.
89. UENO, H., K. SASAKI, H. HONDA, T. NAKAMOTO, T. YAMAGATA, K. MIYAGAWA, K., MITANI, Y. YAZAKI, and H. HIRAI. 1998. c-Cbl is tyrosine-phosphorylated by interleukin-4 and enhances mitogenic and survival signals of interleukin-4 receptor by linking with the phosphatidylinositol 3′-kinase pathway. Blood 91: 46.
90. WELHAM, M. J., U. DECHERT, K. B. LESLIE, F. JIRIK, and J. W. SCHRADER. 1994. Interleukin (IL)-3 and granulocyte/macrophage colony-stimulating factor, but not IL-4, induce tyrosine phosphorylation, activation, and association of SHPTP2 with Grb2 and phosphatidylinositol 3′-kinase. J Biol Chem 269: 23764.
91. FOLTZ, I. N., J. C. LEE, P. R. YOUNG, and J. W. SCHRADER. 1997. Hemopoietic growth factors with the exception of interleukin-4 activate the p38 mitogen-activated protein kinase pathway. J Biol Chem 272: 3296.
92. COFFER, P. J., R. C. SCHWEIZER, G. R. DUBOIS, T. MAIKOE, J. W. LAMMERS, and L. KOENDERMAN. 1998. Analysis of signal transduction pathways in human eosinophils activated by chemoattractants and the T-helper 2-derived cytokines interleukin-4 and interleukin-5. Blood 91: 2547.
93. SUTTLES, J., D. M. MILHORN, R. W. MILLER, J. C. POE, L. M. WAHL, and R. D. STOUT. 1999. CD40 signaling of monocyte inflammatory cytokine synthesis through an ERK1/2-dependent pathway. A target of interleukin (il)-4 and il-10 anti-inflammatory action. J Biol Chem 274: 5835.
94. NIIRO, H., T OTSUKA., E. OGAMI, K. YAMAOKA, S. NAGANO, M. AKAHOSHI, H. NAKASHIMA, Y. ARINOBU, K. IZUHARA, and Y. NIHO. 1998. MAP kinase pathways as a route for regulatory mechanisms of IL-10 and IL-4 which inhibit COX-2 expression in human monocytes. Biochem Biophys Res Commun 250: 200.
95. MARSHALL, L. A., M. J. HANSBURY, B. J. BOLOGNESE, R. J. GUM, P. R. YOUNG, and R. J. MAYER. 1998. Inhibitors of the p38 mitogen-activated kinase modulate IL-4 induction of low affinity IgE receptor (CD23) in human monocytes. J Immunol 161: 6005.
96. WERY, S., M. LETOURNEUR, J. BERTOGLIO, and J. PIERRE. 1996. Interleukin-4 induces activation of mitogen-activated protein kinase and phosphorylation of shc in human keratinocytes. J Biol Chem 271: 8529.
97. HAQUE, S. J., P. HARBOR, M. TABRIZI, T. YI, and B. R. WILLIAMS. 1998. Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4-and IL-13-dependent signal transduction. J Biol Chem 273: 33893.
98. IMANI, F., B. RAGERX, B. CATIPOVIC, and D. G. MARSH. 1997. Interleukin-4 (IL-4) induces phosphatidylinositol 3-kinase (p85) dephosphorylation. Implications for the role of SHP-1 in the IL-4-induced signals in human B cells. J Biol Chem 272: 7927.
99. KUHNE, M. R., T. PAWSON, G. E. LIENHARD, and G. S. FENG. 1993. The insulin receptor substrate 1 associates with the SH2-containing phosphotyrosine phosphatase Syp. J Biol Chem 268: 11479.
100. GADINA, M., L. M. STANCATO, C. M. BACON, A. C. LARNER, and J. J. O'SHEA. 1998. Involvement of SHP-2 in multiple aspects of IL-2 signaling: evidence for a positive regulatory role. J Immunol 160: 4657.
101. ZAMORANO, J., and A. D. KEEGAN. 1998. Regulation of apoptosis by tyrosine-containing domains of IL-4R alpha: Y497 and Y713, but not the STAT6-docking tyrosines, signal protection from apoptosis. J Immunol 161: 859.
102. NELMS, K., A. L. SNOW, J. HU-LI, and W. E. PAUL. 1998. FRIP, a hematopoietic cell-specific rasGAP-interacting protein phosphorylated in response to cytokine stimulation. Immunity 9: 13.
103. NICHOLSON, S. E., and D. J. HILTON. 1998. The SOCS proteins: a new family of negative regulators of signal transduction. J Leukoc Biol 63: 665.
104. LOSMAN, J. A., X. P. CHEN, D. HILTON, and P. ROTHMAN. 1999. Cutting edge: SOCS-1 is a potent inhibitor of IL-4 signal transduction. J Immunol 162: 3770.
105. NOBEN-TRAUTH, N., L. D. SHULTZ, F. BROMBACHER, J. F. URBAN, JR., H. GU, and W. E. PAUL. 1997. An interleukin 4 (IL-4)-independent pathway for CD4+ T cell IL-4 production is revealed in IL-4 receptor-deficient mice. Proc Natl Acad Sci U S A 94: 10838.
106. Mohrs, M., Ledermann, B., Kohler, G., Dorfmuller, A., Gessner, A., and Brombacher, F. 1999. Differences between IL-4-and IL-4 receptor alpha-deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signaling. J Immunol 162: 7302.
107. NOBEN-TRAUTH, N., W. E. PAUL, and D. L. SACKS. 1999. IL-4-and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains. J Immunol 162: 6132.
108. COHN, L., R. J. HOMER, H. MACLEOD, M. MOHRS, F. BROMBACHER, and K. BOTTOMLY, 1999. Th2-induced airway mucus production is dependent on IL-4Ralpha, but not on eosinophils. J Immunol 162: 6178.
109. JANKOVIC, D., M. C. KULLBERG, N. NOBEN-TRAUTH, P. CASPAR, J. M. WARD, A. W. CHEEVER, W. E. PAUL, and A. SHER. 1999. Schistosome-infected IL-4 receptor knockout (KO) mice, in contrast to IL-4 KO mice, fail to develop granulomatous pathology while maintaining the same lymphokine expression profile. J Immunol 163: 337.
110. ROSE-JOHN, S., and P. C. HEINRICH. 1994. Soluble receptors for cytokines and growth factors: generation and biological function. Biochem J 300: 281.
111. FERNANDEZ-BOTRAN, R., P. M. CHILTON, and Y. MA. 1996. Soluble cytokine receptors: their roles in immunoregulation, disease, and therapy. Adv Immunol 63: 269.
112. HEANEY, M. L., and D. W. GOLDE. 1998. Soluble receptors in human disease. J Leukoc Biol 64: 135.
113. FANSLOW, W. C., K. CLIFFORD, T VANDENBOS., A. TEEL, R. J. ARMITAGE, and M. P. BECKMANN. 1990. A soluble form of the interleukin 4 receptor in biological fluids. Cytokine 2: 398.
114. FERNANDEZ-BOTRAN, R., and E. S. VITETTA. 1990. A soluble, high-affinity, interleukin-4-binding protein is present in the biological fluids of mice. Proc Natl Acad Sci U S A 87: 4202.
115. SANG, D. K., J. H. OUMA, C. C. JOHN, C. C. WHALEN, C. L. KING, A. A. MAHMOUD, and F. P. HEINZEL. 1999. Increased levels of soluble interleukin-4 receptor in the sera of patients with visceral leishmaniasis. J Infect Dis 179: 743.
116. GARRONE, P., O. DJOSSOU, J. P GALIZZI., and J. Banchereau. 1991. A recombinant extracellular domain of the human interleukin 4 receptor inhibits the biological effects of interleukin 4 on T and B lymphocytes. Eur J Immunol 21: 1365.
117. MALISZEWSKI, C. R., T. A. SATO, T. VANDEN BOS, S. WAUGH, S. K. DOWER, J. SLACK, M. P. BECKMANN, and K. H. GRABSTEIN. 1990. Cytokine receptors and B cell functions. I. Recombinant soluble receptors specifically inhibit IL-1-and IL-4-induced B cell activities in vitro. J Immunol 144: 3028.
118. FERNANDEZ-BOTRAN, R., and E. S. VITETTA. 1991. Evidence that natural murine soluble interleukin 4 receptors may act as transport proteins. J Exp Med 174: 673.
119. FANSLOW, W. C., K. N. CLIFFORD, L. S. PARK, A. S. RUBIN, R. F. VOICE, M. P. BECKMANN, and M. B. WIDMER. 1991. Regulation of alloreactivity in vivo by IL-4 and the soluble IL-4 receptor. J Immunol 147: 535.
120. RENZ, H., K. ENSSLE, L. LAUFFER, R. KURRLE, and E. W. GELFAND. 1995. Inhibition of allergen-induced IgE and IgG1 production by soluble IL-4 receptor. Int Arch Allergy Immunol 106: 46.
121. RENZ, H., K. BRADLEY, K. ENSSLE, J. E. LOADER, E. W. LARSENX, and E. W. GELFAND. 1996. Prevention of the development of immediate hypersensitivity and airway hyperresponsiveness following in vivo treatment with soluble IL-4 receptor. Int Arch Allergy Immunol 109: 167.
122. KOBAYASHI, H., M. KOBAYASHI, T. UTSUNOMIYA, D. N. HERNDON, R. B. POLLARD, and F. SUZUKI. 1999. Therapeutic protective effects of IL-12 combined with soluble IL-4 receptor against established infections of herpes simplex virus type 1 in thermally injured mice. J Immunol 162: 7148.
123. SATO, T. A., M. B. WIDMER, F. D. FINKELMAN, H. MADANI, C. A. JACOBS, K. H. GRABSTEIN, and C. R. MALISZEWSKI. 1993. Recombinant soluble murine IL-4 receptor can inhibit or enhance IgE responses in vivo. J Immunol 150: 2717.
124. CHILTON, P. M., and R. FERNANDEZ-BOTRAN. 1997. Regulation of the expression of the soluble and membrane forms of the murine IL-4 receptor. Cell Immunol 180: 104.
125. FERNANDFZ-BOTRAN, R., T. A. WYNN, S. HIENY, P. CASPAR, P. M. CHILTON, and A. SHER. 1995. Linked in vivo expression of soluble interleukin-4 receptor and interleukin-4 in murine schistosomiasis. Eur J Immunol 25: 649.
126. BLUM, H., M. WOLF, K. ENSSLE, M. ROLLINGHOFF, and A. GESSNER. 1996. Two distinct stimulus-dependent pathways lead to production of soluble murine interleukin-4 receptor. J Immunol 157: 1846.
127. JUNG, T., N. SCHRADER, M. HELLWIG, C. ENSSLEX, and C. NEUMANN. 1999. Soluble human interleukin-4 receptor is produced by activated T cells under the control of metallo-proteinases. Int Arch Allergy Immunol 119: 23.
128. ZHANG, J. G., D. J. HILTON, T. A. WILLSON, C. MCFARLANE, B. A. ROBERTS, R. L. MORITZ, R. J. SIMPSON, W. S. ALEXANDER, D. METCALF, and N. A. NICOLA. 1997. Identification, purification, and characterization of a soluble interleukin (IL)-13-binding protein. Evidence that it is distinct from the cloned Il-13 receptor and Il-4 receptor alpha-chains. J Biol Chem 272: 9474.
129. CHIARAMONTE, M. G., L. R. SCHOPF, T. Y. NEBEN, A. W. CHEEVER, D. D. DONALDSON, and T. A. WYNN. 1999. IL-13 is a key regulatory cytokine for Th2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni eggs. J Immunol 162: 920.
130. POUDRIER, J., P GRABER., S. HERREN, D. GRETENER, G. ELSON, C. BERNEY, J. F. GAUCHAT, and M. H. KOSCO-VILBOIS. 1999. A soluble form of IL-13 receptor alpha 1 promotes IgG2a and IgG2b production by murine germinal center B cells. J Immunol 163: 1153.
131. SCHULTE, T., R. KURRLE, M. ROLLINGHOFF, and A. GESSNER. 1997. Molecular characterization and functional analysis of murine interleukm 4 receptor allotypes. J Exp Med 186: 1419.
132. GRIMBACHER, B., S. M. HOLLAND, and J. M. PUCK. 1998. The interleukin-4 receptor variant Q576R in hyper-IgE syndrome [letter; comment]. N Engl J Med 338: 1073.
133. KRUSE, S., T. JAPHA, M. TEDNER, S. H. SPARHOLT, J. FORSTER, J. KUEHR, and K. A. DEICHMANN. 1999. The polymorphisms S503P and Q576R in the interleukin-4 receptor alpha gene are associated with atopy and influence the signal transduction. Immunology 96: 365.
134. HACKSTEIN, H., H. KLÜTER, L. FRICKE, J. HOYER, and G. BEIN. 1999. The IL-4 receptor alpha-chain variant Q576R is strongly associated with decreased kidney allograft survival. Tissue antigens in press.
135. HACKSTEIN, H., H. HOFMANN, A. BOHNERT, and G. BEIN. 1999. Definition of human interleukin-4 receptor alpha chain haplotypes and allelic association with atopy markers. Human Immunol. in press.
136. NOGUCHI, E., M. SHIBASAKI, T. ARINAMI, K. TAKEDA, Y YOKOUCHI., K. KOBAYASHI, N. IMOTO, S. NAKAHARA, A. MATSUI, and H. HAMAGUCHI. 1999. Lack of association of atopy/asthma and the interleukin-4 receptor alpha gene in Japanese. Clin Exp Allergy 29: 228.
137. MITSUYASU, H., K. IZUHARA, X. Q. MAO, P. S. GAO, Y. ARINOBU, T. ENOMOTO, M. KAWAI, S. SASAKI, Y DAKE., N. HAMASAKI, T. SHIRAKAWA, and J. M. HOPKIN. 1998. Ile50Val variant of IL4R alpha upregulates IgE synthesis and associates with atopic asthma [letter]. Nat Genet 19: 119.
138. HERSHEY, G. K., M. F. FRIEDRICH, L. A. ESSWEIN, M. L. THOMAS, and T. A. CHATILA. 1997. The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor [see comments]. N Engl J Med 337: 1720.
139. WANG, H. Y., C. P. SHELBURNE, J. ZAMORANO, A. E. KELLY, J. J. RYAN, and A. D. KEEGAN. 1999. Cutting edge: effects of an allergy-associated mutation in the human IL-4R alpha (Q576R) on human IL-4-induced signal transduction. J Immunol 162: 4385.
140. MITSUYASU, H., Y. YANAGIHARA, X. Q. MAO, P. S. GAO, Y ARINOBU., K. IHARA, A. TAKABAYASHI, T. HARA, T. ENOMOTO, S. SASAKI, M. KAWAI, N. HAMASAKI, T. SHIRAKAWA, J. M. HOPKIN, and K. IZUHARA. 1999. Cutting edge: dominant effect of Ile50Val variant of the human IL-4 receptor alpha-chain in IgE synthesis. J Immunol 162: 1227.
141. DEICHMANN, K., J. BARDUTZKY, J. FORSTER, A. HEINZMANN, and J. KUEHR. 1997. Common polymorphisms in the coding part of the IL4-receptor gene. Biochem Biophys Res Commun 231: 696.
142. PARRY, R. G., K. M. GILLESPIE, A. PARNHAM, A. G. CLARK, and P. W. MATHIESON. 1999. Interleukin-4 and interleukin-4 receptor polymorphisms in minimal change nephropathy. Clin Sci (Colch) 96: 665.
143. KANEMITSU, S., A. TAKABAYASHI, Y. SASAKI, R. KUROMARU, K. IHARA, Y. KAKU, K. SAKAI, and T. HARA. 1999. Association of interleukin-4 receptor and interleukin-4 promoter gene polymorphisms with systemic lupus erythematosus. Arthritis Rheum 42: 1298.